<--- Back to Details
First PageDocument Content
Arthritis / Rheumatology / Immunosuppressants / Psoriasis / Rheumatoid arthritis / Ankylosing spondylitis / Psoriatic nails / Psoriatic arthritis / Secukinumab / Medicine / Health / Autoimmune diseases
Date: 2015-05-13 10:22:08
Arthritis
Rheumatology
Immunosuppressants
Psoriasis
Rheumatoid arthritis
Ankylosing spondylitis
Psoriatic nails
Psoriatic arthritis
Secukinumab
Medicine
Health
Autoimmune diseases

Novartis Pharmaceuticals Canada Inc. 385 Bouchard Boulevard Dorval, Quebec H9S 1A9 www.novartis.ca http://www.novartis.com

Add to Reading List

Source URL: www.novartis.ca

Download Document from Source Website

File Size: 441,97 KB

Share Document on Facebook

Similar Documents

BIOLOGICS IN THE PRACTICE OF LAW LINDSAY KELLY* Biologics have come to occupy an increasingly important role in the medical industry, accounting for well over $200 billion in worldwide sales inNot surprisingly, bi

BIOLOGICS IN THE PRACTICE OF LAW LINDSAY KELLY* Biologics have come to occupy an increasingly important role in the medical industry, accounting for well over $200 billion in worldwide sales inNot surprisingly, bi

DocID: 1rrNB - View Document

Guideline on clinical investigation of medicinal products for the treatment of Multiple Sclerosis rev. 2

Guideline on clinical investigation of medicinal products for the treatment of Multiple Sclerosis rev. 2

DocID: 1rmwo - View Document

EAP Reimbursement Criteria for Frequently Requested Drugs

EAP Reimbursement Criteria for Frequently Requested Drugs

DocID: 1rhhE - View Document

UCB Presents Latest Research from Immunology Portfolio at American College of Rheumatology Annual Meeting Data presentations include:  Positive results from Period 1 of the C-EARLY™ Phase 3 study of CIMZIA® (certol

UCB Presents Latest Research from Immunology Portfolio at American College of Rheumatology Annual Meeting Data presentations include:  Positive results from Period 1 of the C-EARLY™ Phase 3 study of CIMZIA® (certol

DocID: 1rakB - View Document

TABLE OF CONTENTS  INTRODUCTION 2

TABLE OF CONTENTS INTRODUCTION 2

DocID: 1qY7G - View Document